Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is an 18-week, double-blind, multicenter study with gradual conversion from previous
antiepileptic therapy to eslicarbazepine acetate monotherapy in subjects with partial
epilepsy.